UniProt ID | NNMT_HUMAN | |
---|---|---|
UniProt AC | P40261 | |
Protein Name | Nicotinamide N-methyltransferase | |
Gene Name | NNMT | |
Organism | Homo sapiens (Human). | |
Sequence Length | 264 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Catalyzes the N-methylation of nicotinamide and other pyridines to form pyridinium ions. This activity is important for biotransformation of many drugs and xenobiotic compounds.. | |
Protein Sequence | MESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKKEPEAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MESGFTSKDT -----CCCCCCCCCC | 37.60 | - | |
8 | 2-Hydroxyisobutyrylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | - | |
8 | Ubiquitination | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | - | |
8 | Succinylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | 23954790 | |
8 | Acetylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | 27452117 | |
8 | "N6,N6-dimethyllysine" | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | - | |
8 | Methylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | 23644510 | |
11 | Phosphorylation | GFTSKDTYLSHFNPR CCCCCCCCHHHCCHH | 19.15 | 25159151 | |
13 | Phosphorylation | TSKDTYLSHFNPRDY CCCCCCHHHCCHHHH | 18.67 | 28857561 | |
23 | Ubiquitination | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | - | |
23 | Succinylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | 23954790 | |
23 | 2-Hydroxyisobutyrylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | - | |
23 | Acetylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | 27178108 | |
23 | Malonylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | 26320211 | |
24 | Phosphorylation | PRDYLEKYYKFGSRH HHHHHHHHHHHCCCC | 11.51 | - | |
25 | Phosphorylation | RDYLEKYYKFGSRHS HHHHHHHHHHCCCCC | 15.77 | - | |
26 | Malonylation | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | 26320211 | |
26 | 2-Hydroxyisobutyrylation | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | - | |
26 | Acetylation | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | 26051181 | |
26 | Ubiquitination | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | - | |
29 | Phosphorylation | EKYYKFGSRHSAESQ HHHHHHCCCCCHHHH | 29.92 | 27690223 | |
32 | Phosphorylation | YKFGSRHSAESQILK HHHCCCCCHHHHHHH | 32.40 | 20068231 | |
35 | Phosphorylation | GSRHSAESQILKHLL CCCCCHHHHHHHHHH | 23.41 | 20068231 | |
39 | Acetylation | SAESQILKHLLKNLF CHHHHHHHHHHHHHH | 33.56 | 19608861 | |
39 | Ubiquitination | SAESQILKHLLKNLF CHHHHHHHHHHHHHH | 33.56 | 19608861 | |
39 | Malonylation | SAESQILKHLLKNLF CHHHHHHHHHHHHHH | 33.56 | 26320211 | |
43 | Acetylation | QILKHLLKNLFKIFC HHHHHHHHHHHHHHC | 58.95 | 23954790 | |
43 | Ubiquitination | QILKHLLKNLFKIFC HHHHHHHHHHHHHHC | 58.95 | - | |
47 | Ubiquitination | HLLKNLFKIFCLDGV HHHHHHHHHHCCCCC | 37.73 | - | |
47 | 2-Hydroxyisobutyrylation | HLLKNLFKIFCLDGV HHHHHHHHHHCCCCC | 37.73 | - | |
47 | Acetylation | HLLKNLFKIFCLDGV HHHHHHHHHHCCCCC | 37.73 | 26051181 | |
96 | Ubiquitination | QNLQELEKWLKKEPE HCHHHHHHHHHHCCC | 71.14 | - | |
100 | Ubiquitination | ELEKWLKKEPEAFDW HHHHHHHHCCCCCCC | 76.08 | - | |
108 | Phosphorylation | EPEAFDWSPVVTYVC CCCCCCCCCEEEEEE | 15.06 | 25159151 | |
113 | Phosphorylation | DWSPVVTYVCDLEGN CCCCEEEEEEECCCC | 6.35 | 24927040 | |
123 | Ubiquitination | DLEGNRVKGPEKEEK ECCCCCCCCHHHHHH | 66.56 | - | |
136 | Ubiquitination | EKLRQAVKQVLKCDV HHHHHHHHHHHCCCC | 37.39 | - | |
185 | Phosphorylation | RALRNLGSLLKPGGF HHHHHHHHHCCCCEE | 33.42 | 24719451 | |
201 | Phosphorylation | VIMDALKSSYYMIGE EEEEHHHHCEEEECC | 25.15 | 27642862 | |
203 | Phosphorylation | MDALKSSYYMIGEQK EEHHHHCEEEECCCC | 12.25 | 27642862 | |
204 | Phosphorylation | DALKSSYYMIGEQKF EHHHHCEEEECCCCC | 5.56 | 27642862 | |
205 | Sulfoxidation | ALKSSYYMIGEQKFS HHHHCEEEECCCCCC | 2.11 | 30846556 | |
210 | Ubiquitination | YYMIGEQKFSSLPLG EEEECCCCCCCCCCC | 42.80 | - | |
261 | Phosphorylation | SLVARKLSRPL---- HHHHHHHCCCC---- | 34.58 | 23927012 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NNMT_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NNMT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NNMT_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
GLOD4_HUMAN | GLOD4 | physical | 26344197 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00627 | Niacin |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-39, AND MASS SPECTROMETRY. |